Matt TurnerPatient Affordability
Liz KaneImpactful Strategy
Brenda SnowAuthentic Patient Voice
Amy GilesIncreasing Engagement
Stacey GandlerBrand Nourishment
Matthew DurhamOmnidynamic Marketing
Pat PurcellMeeting Engagement
Daniel SontupeMarket Access
Paul TheisenPatient Acquisition
Bud BilanichSuccess Coach
Joey CohenMedication Adherence
Frank BurrellScientific Storytelling
Suma Ramadas, PhDMedical Affairs
David LinetskyPoint-of-Care Marketing
--NUZYRA™ (omadacycline) approved by FDA for the treatment of CABP and ABSSSI -- -- ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email